Drug Shortage Report for GLN-URSODIOL
| Report ID | 242235 |
| Drug Identification Number | 02426919 |
| Brand name | GLN-URSODIOL |
| Common or Proper name | Ursodiol |
| Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | URSODIOL |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 tablets |
| ATC code | A05AA |
| ATC description | BILE THERAPY |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-11-01 |
| Actual start date | 2024-11-02 |
| Estimated end date | 2024-12-18 |
| Actual end date | 2024-12-20 |
| Shortage status | Resolved |
| Updated date | 2024-12-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2024-12-23 | French | Compare |
| v7 | 2024-12-23 | English | Compare |
| v6 | 2024-12-16 | French | Compare |
| v5 | 2024-12-16 | English | Compare |
| v4 | 2024-11-18 | French | Compare |
| v3 | 2024-11-18 | English | Compare |
| v2 | 2024-11-07 | French | Compare |
| v1 | 2024-11-07 | English | Compare |
Showing 1 to 8 of 8